Schedule 13G ownership disclosure

PASITHEA THERAPEUTICS CORP

Security class unavailable · CUSIP: 70261F103

Event date: 2022-06-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
26,086,961
Percent of class
9.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-007318
Form type
SC 13G
Filer
Manning Paul B
CIK
CIK 1494695
Filed
Jun 29, 2022
Reporting period
Jun 22, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub